Exam 14: Pediatric Disease With Respiratory Implications
Exam 1: Making Sense of Caring for Kids: a Different Approach to Respiratory Care25 Questions
Exam 2: Fetal Cardiopulmonary Development25 Questions
Exam 3: Resuscitation of the Newborn During Transition to Extrauterine Life19 Questions
Exam 4: Respiratory Distress Syndrome34 Questions
Exam 5: Apnea of Prematurity and Bronchopulmonary Dysplasia22 Questions
Exam 6: Disease of Full-Term Infants23 Questions
Exam 7: Common Neonatal Complications: Pulmonary Complications17 Questions
Exam 8: Common Neonatal Complications: Multisystem Complications25 Questions
Exam 9: Abdominal Defects21 Questions
Exam 10: Airway Abnormalities22 Questions
Exam 11: Acyanotic Heart Defects22 Questions
Exam 12: Cyanotic Heart Defects20 Questions
Exam 13: Asthma29 Questions
Exam 14: Pediatric Disease With Respiratory Implications20 Questions
Exam 15: Pediatric Pulmonary Diseases31 Questions
Exam 16: Pediatric Infectious Airway Diseases22 Questions
Exam 17: Neuromuscular Disorders25 Questions
Exam 18: Pediatric Diseases With Respiratory Implications20 Questions
Exam 19: Neurological Accidents19 Questions
Exam 20: Ethics in Perinatal and Pediatric Respiratory Care20 Questions
Exam 21: Palliative and End of Life Care17 Questions
Select questions type
What are the three phases of autogenic drainage
Free
(Multiple Choice)
4.8/5
(92)
Correct Answer:
A
What pulmonary function test marker(s) best Correlate with instances of mortality in patients with cystic fibrosis
I.Forced vital capacity
II.Forced expiratory volume after 1 seCond divided by forced expiratory volume after 6 seConds
III.Functional residual capacity
IV.Forced expiratory volume after 1 seCond
Free
(Multiple Choice)
4.9/5
(76)
Correct Answer:
D
Which of the following practices facilitate muCous clearance in patients with cystic fibrosis
I.Positive expiratory pressure therapy
II.Low-frequency inspiratory oscillation
III.Positive end-expiratory pressure therapy
IV.High-frequency expiratory oscillation
Free
(Multiple Choice)
4.8/5
(84)
Correct Answer:
D
Which of the following are Contraindications to lung transplantation for patients with cystic fibrosis
I.Poor adherence to therapy
II.Normal body mass index
III.UnControlled diabetes
IV.Colonization with resistant organisms
(Multiple Choice)
4.7/5
(71)
What information should be Considered when creating an individualized treatment plan for a patient with cystic fibrosis
I.Age
II.Gender
III.Symptoms
IV.Pulmonary function test results
V.Severity of lung disease
(Multiple Choice)
5.0/5
(91)
Which of the following are muColytic agents
I.Dornase alfa
II.Pulmozyme
III.Hypotonic saline solutions
IV.Tobramycin
V.Acetylcysteine
(Multiple Choice)
4.9/5
(81)
What is Considered the most Common life-shortening genetic disease among Caucasians
(Multiple Choice)
5.0/5
(77)
What was the median survival age for patients with cystic fibrosis as of 2010
(Multiple Choice)
4.8/5
(75)
What percentage of adults with cystic fibrosis (CF) develop CF-related diabetes
(Multiple Choice)
4.7/5
(76)
Which of the following techniques are not Considered when managing a patient with cystic fibrosis
I.Airway clearance technique
II.Bronchial hygiene therapy
III.Hig- frequency chest wall oscillation
IV.Total chest breathing technique
V.High-pressure positive expiratory pressure therapy
VI.Drainage autogenic dyssynchrony
VII.Intrapulmonary percussive ventilation
VIII.Aerosol therapy and muColytic therapy
(Multiple Choice)
4.9/5
(87)
What are some symptoms that Could signify the presence of cystic fibrosis
I.Difficulty gaining weight
II.Abnormal stools
III.Potassium deficiency
IV.CT scan revealing bronchiectasis and muCous plugging
(Multiple Choice)
4.9/5
(81)
What is the standardized order for delivery of inhaled medications and airway clearance
(Multiple Choice)
4.8/5
(89)
What role does exercise play in improving lung function for patients with cystic fibrosis
I.Increase minute ventilation
II.Decrease minute ventilation
III.Decrease expiratory flow
IV.Increase expiratory flow
(Multiple Choice)
4.9/5
(80)
What factors hasten the progression of lung disease in patients with cystic fibrosis
I.Infection with Pseudomonas aeruginosa
II.Infection with Burkholderia cenocepacia
III.Male patient
IV.Diabetes
V.Exposure to seCondhand smoke
(Multiple Choice)
4.8/5
(73)
What is the reCognized testing standard for diagnosing cystic fibrosis
I.Sweat test
II.Pilocarpine iontophoresis
III.Cystic fibrosis transmembrane Conductance regulator gene sequencing
IV.Nasal potential difference
(Multiple Choice)
4.9/5
(81)
What is the most Common bacterium found in the airways of patients with cystic fibrosis
(Multiple Choice)
4.9/5
(80)
What is the only FDA-approved nebulizer for use with inhaled tobramycin
(Multiple Choice)
4.9/5
(72)
Which of the following inhaled antibiotics are approved to treat a patient with cystic fibrosis
I.Tobramycin
II.Aztreonam
III.Pulmozyme
IV.Colistin
(Multiple Choice)
4.8/5
(76)
What percentage of patients with cystic fibrosis present with bowel obstructions
(Multiple Choice)
4.9/5
(86)
What action should be performed to stop transmission of pathogens from one cystic fibrosis patient to another
(Multiple Choice)
4.9/5
(78)
Filters
- Essay(0)
- Multiple Choice(0)
- Short Answer(0)
- True False(0)
- Matching(0)